Meloxicam in Combination with Mitoxantrone or Vinblastine as First-Line Treatment for Non-Resectable Urothelial Cell Carcinoma in Dogs

SIMPLE SUMMARY: Meloxicam is a readily available non-steroidal anti-inflammatory medication that is commonly used in clinical practice. It has been associated with a low incidence of gastrointestinal adverse effects in comparison to other non-steroidal anti-inflammatory medications and it has also d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciriano Cerdà, Estel.la, Zajc, Alenka Lavra, Finotello, Riccardo, Macdonald, Kirsty, Lyseight, Filipa, Van Den Steen, Nele, Sanchez Gonzalez, Katia, Marrington, Mary, Grant, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458788/
https://www.ncbi.nlm.nih.gov/pubmed/37624316
http://dx.doi.org/10.3390/vetsci10080529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458788/
https://www.ncbi.nlm.nih.gov/pubmed/37624316
http://dx.doi.org/10.3390/vetsci10080529

Ejemplares similares